cefaclor anhydrous has been researched along with Skin Diseases, Bacterial in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y; Ding, L; Li, T; Li, W; Ma, JJ; Xia, D; Xiang, H; Xie, X | 1 |
| Nolen, T | 1 |
| Drehobl, M; Pien, F; Stevens, DL | 1 |
| Thornsberry, C | 1 |
| Dere, WH; Senetar, JE; Stotka, JL; Therasse, DG | 1 |
1 review(s) available for cefaclor anhydrous and Skin Diseases, Bacterial
| Article | Year |
|---|---|
Comparative studies of cefprozil in the management of skin and soft-tissue infections.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Skin Diseases, Bacterial; Soft Tissue Infections | 1994 |
1 trial(s) available for cefaclor anhydrous and Skin Diseases, Bacterial
| Article | Year |
|---|---|
Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections.
Topics: Administration, Oral; Adult; Bacterial Infections; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Connective Tissue Diseases; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Prodrugs; Safety; Skin Diseases, Bacterial; Staphylococcal Infections | 1993 |
3 other study(ies) available for cefaclor anhydrous and Skin Diseases, Bacterial
| Article | Year |
|---|---|
Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: Two case reports.
Topics: Anti-Bacterial Agents; Cefaclor; Child; China; Female; Guanine Nucleotide Exchange Factors; Humans; Job Syndrome; Male; Skin Diseases, Bacterial; STAT3 Transcription Factor | 2019 |
Cefaclor AF: correlation of microbiology and clinical outcome.
Topics: Bronchitis; Cefaclor; Chemistry, Pharmaceutical; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseriaceae Infections; Pneumonia; Skin Diseases, Bacterial; Urinary Tract Infections | 1992 |
Comprehensive safety profile of cefaclor AF in respiratory, urinary tract and skin infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefaclor; Chemistry, Pharmaceutical; Child; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Nausea; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1992 |